Huang M, Wang L, Zhang Q, Zhou L, Liao R, Wu A
Pharmaceuticals (Basel). 2024; 17(1).
PMID: 38256942
PMC: 10820339.
DOI: 10.3390/ph17010109.
Cook S
Biochem J. 2023; 480(23):1987-2008.
PMID: 38054591
PMC: 10754292.
DOI: 10.1042/BCJ20220160.
Gouife M, Zhu S, Huang K, Nawaz M, Yue X, Ma R
Fish Shellfish Immunol Rep. 2023; 5:100117.
PMID: 37771817
PMC: 10523422.
DOI: 10.1016/j.fsirep.2023.100117.
Kumar B, Afshar-Kharghan V, Mendt M, Sackstein R, Tanner M, Popat U
Front Immunol. 2022; 13:1018047.
PMID: 36203567
PMC: 9530569.
DOI: 10.3389/fimmu.2022.1018047.
Maroni P, Bendinelli P, Ferraretto A, Lombardi G
Biomedicines. 2021; 9(6).
PMID: 34201209
PMC: 8228851.
DOI: 10.3390/biomedicines9060659.
Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.
Li Y, Zhang J, Shi J, Liu K, Wang X, Jia Y
Stem Cell Res Ther. 2021; 12(1):221.
PMID: 33789737
PMC: 8010995.
DOI: 10.1186/s13287-021-02290-0.
Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11.
Metcalfe R, Putoczki T, Griffin M
Front Immunol. 2020; 11:1424.
PMID: 32765502
PMC: 7378365.
DOI: 10.3389/fimmu.2020.01424.
IL-11 in cardiac and renal fibrosis: Late to the party but a central player.
Corden B, Adami E, Sweeney M, Schafer S, Cook S
Br J Pharmacol. 2020; 177(8):1695-1708.
PMID: 32022251
PMC: 7070163.
DOI: 10.1111/bph.15013.
Comparative evaluation of C-reactive protein and complete blood count in chronic periodontitis patients following Phase I therapy: A serological and hematological study.
Luthra S, Grover H, Singh A, Lall A, Masamatti S
J Indian Soc Periodontol. 2019; 23(6):525-533.
PMID: 31849397
PMC: 6906908.
DOI: 10.4103/jisp.jisp_639_18.
PKC-epsilon deficiency alters progenitor cell populations in favor of megakaryopoiesis.
Kostyak J, Liverani E, Kunapuli S
PLoS One. 2017; 12(8):e0182867.
PMID: 28783756
PMC: 5544228.
DOI: 10.1371/journal.pone.0182867.
IL-11 induces differentiation of myeloid-derived suppressor cells through activation of STAT3 signalling pathway.
Sumida K, Ohno Y, Ohtake J, Kaneumi S, Kishikawa T, Takahashi N
Sci Rep. 2017; 5:13650.
PMID: 28781374
PMC: 4642551.
DOI: 10.1038/srep13650.
Safety and Efficacy of Megakaryocytes Induced from Hematopoietic Stem Cells in Murine and Nonhuman Primate Models.
Guan X, Qin M, Zhang Y, Wang Y, Shen B, Ren Z
Stem Cells Transl Med. 2017; 6(3):897-909.
PMID: 28297572
PMC: 5442772.
DOI: 10.5966/sctm.2016-0224.
Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation.
Zhong Z, Hu Z, Jiang Y, Sun R, Chen X, Chu H
Oncotarget. 2016; 7(37):59652-59663.
PMID: 27487122
PMC: 5312338.
DOI: 10.18632/oncotarget.10831.
Recent developments in ex vivo platelet production.
Wahyu Nurhayati R, Ojima Y, Taya M
Cytotechnology. 2016; 68(6):2211-2221.
PMID: 27002966
PMC: 5101314.
DOI: 10.1007/s10616-016-9963-4.
Unique gene expression profile of the proliferating Xenopus tadpole tail blastema cells deciphered by RNA-sequencing analysis.
Tsujioka H, Kunieda T, Katou Y, Shirahige K, Kubo T
PLoS One. 2015; 10(3):e0111655.
PMID: 25775398
PMC: 4361676.
DOI: 10.1371/journal.pone.0111655.
Designer cytokine hyper interleukin 11 (H11) is a megakaryopoietic factor.
Dams-Kozlowska H, Kwiatkowska-Borowczyk E, Gryska K, Mackiewicz A
Int J Med Sci. 2013; 10(9):1157-65.
PMID: 23869192
PMC: 3714392.
DOI: 10.7150/ijms.5638.
Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.
Calon A, Espinet E, Palomo-Ponce S, Tauriello D, Iglesias M, Cespedes M
Cancer Cell. 2012; 22(5):571-84.
PMID: 23153532
PMC: 3512565.
DOI: 10.1016/j.ccr.2012.08.013.
Proapoptotic and antiapoptotic actions of Stat1 versus Stat3 underlie neuroprotective and immunoregulatory functions of IL-11.
Zhang J, Zhang Y, Dutta D, Argaw A, Bonnamain V, Seto J
J Immunol. 2011; 187(3):1129-41.
PMID: 21709156
PMC: 3164308.
DOI: 10.4049/jimmunol.1004066.
A multicenter randomized, double-blind, placebo-controlled late-phase II/III study of recombinant human interleukin 11 in acute myelogenous leukemia.
Usuki K, Urabe A, Ikeda Y, Ohashi Y, Mizoguchi H, Takaku F
Int J Hematol. 2007; 85(1):59-69.
PMID: 17261503
DOI: 10.1532/IJH97.06027.
Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation.
Zhang Y, Taveggia C, Melendez-Vasquez C, Einheber S, Raine C, Salzer J
J Neurosci. 2006; 26(47):12174-85.
PMID: 17122042
PMC: 6675431.
DOI: 10.1523/JNEUROSCI.2289-06.2006.